MarketInOut Stock Screener Log In | Sign Up
 

Lunai Bioworks Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/07/2026 16:00
Lunai Bioworks Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.89 mln
Float2.52 mln
Earnings Date09/28/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

1 / 100
Severely lagging

Pre-Tax Margin

-612,568%
Severely loss-making

ROE

-2,076
Deeply negative

Altman Z-Score

-117
Deeply distressed

ROA

-429
Deeply negative

Business Description

Lunai Bioworks Inc. is a Los Angeles-based biotechnology company operating in the United States and the Netherlands, focused on developing treatments and diagnostic tools for cancer. The company is working on genetically engineered cell-based vaccines designed to target solid tumors, including pancreatic and breast cancers, alongside an artificial intelligence platform that can detect cancer and its return at an early stage, even before symptoms appear. Formerly known as Renovaro Inc., the company also has a presence in biodefense.

Key Fundamentals

EPS-61.52
ROE-2,076
RPS0.01
ROIC-29.11
ROA-429
Interest Cover-16.23
EBITDA, mln-128
EV / EBITDA-0.43
Revenue, mln0.02
EV / Revenue29.57

Quote Details

Last 1.09
Change -0.04 (-3.54%)
Open 1.19
Volume 19,887
Turnover 21,677
Average Volume 49,576

Financial Ratios

Pre-Tax Profit Margin-612,568
Current Ratio0.19
Price / Sales213

Financial Strength

Altman Z-Score-117
Piotroski F-Score 4 / 9
Short Ratio4.12
Short % of Float3.38

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -25.85% 1 / 100   
1 Month -58.08% 1 / 100   
2 Months -64.72% 4 / 100   
6 Months -61.89% 7 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us